“I ignored TD until the unintentional movements started affecting my work. I finally had to say ‘it’s not ok.’ It was time to talk to my doctor about AUSTEDO.”

Model is not an actual patient

In clinical studies, AUSTEDO (deutetrabenazine) tablets effectively reduced tardive dyskinesia (TD) movements while people continued with their current mental health medications.1,2

A man carrying a box in a warehouse. A man carrying a box in a warehouse.

Model is not an actual patient

What is Tardive Dyskinesia movements (TD)?

If you experience unintentional movements, it could be tardive dyskinesia. TD appears as mild to severe twitching, shaking or jerking in the hands, feet, face, or torso. Involuntary blinking, tongue movements and other unintentional, uncontrollable movements can also be signs of TD.3, 4

Recognize symptoms

Hear from patients who've had success managing TD

“It was great to know that this was a disease with a name, and that there was treatment”

Patient who takes AUSTEDO® (deutetrabenazine). Patient who takes AUSTEDO® (deutetrabenazine).

–Angi, TD Patient Individual results may vary

Now that my movements are being managed,I am able to do some of the things I love.

—Angi, TD Patient Individual results may vary

Purple image with white letters that says "$0 for your first 30 days of treatment."

The 30-day Free Trial Voucher is only for new patients. Voucher is good for up to 4 weeks of titration or 30 days of medication.

Shared Solutions®—the go-to resource for coverage and financial questions about AUSTEDO (deutetrabenazine) tablets.

Explore financial support Or call us at 1-800-887-8100

Need help discussing movements with your doctor?

Downloadable resources, including the Doctor Discussion Guide, are available here to help you prepare for a conversation with your doctor.

Two pieces of paper, one laying over
the other at an angle, with text that says
"It's not ok." Two pieces of paper, one laying over
the other at an angle, with text that says
"It's not ok."
Man with barcode scanner scanning a label posted on a brown box. Man with barcode scanner scanning a label posted on a brown box.

Model is not an actual patient

Receive updates

Sign up to have information about AUSTEDO and tardive dyskinesia emailed to you.

REGISTER NOW

You are about to leave this site

You are about to leave AUSTEDO.com and enter a website operated by a third party. Teva is not responsible for and does not control the content contained on this third-party website linked to AUSTEDO.com.

Are you a healthcare professional?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?

References: 1. AUSTEDO® (deutetrabenazine) tablets current Prescribing Information. Parsippany, NJ. Teva Neuroscience, Inc. 2. Data on file. Parsippany, NJ; Teva Neuroscience, Inc. 3. Warikoo N, Schwartz T, Citrome L. Tardive dyskinesia. In: Schwartz TL, Megna J, Topel ME, eds. Antipsychotic Drugs: Pharmacology, Side Effects and Abuse Prevention. Nova Science Publishers, Inc; 2013:235-258. 4. Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (N Y). 2013;3:tre-03-161-4138-1. Published online July 12, 2013. doi:10.7916/D88P5Z71